Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tarja J. Karpanen is active.

Publication


Featured researches published by Tarja J. Karpanen.


Journal of Antimicrobial Chemotherapy | 2008

Antimicrobial efficacy of chlorhexidine digluconate alone and in combination with eucalyptus oil, tea tree oil and thymol against planktonic and biofilm cultures of Staphylococcus epidermidis

Tarja J. Karpanen; Tony Worthington; E.R. Hendry; Barbara R. Conway; Peter A. Lambert

OBJECTIVES Effective skin antisepsis and disinfection of medical devices are key factors in preventing many healthcare-acquired infections associated with skin microorganisms, particularly Staphylococcus epidermidis. The aim of this study was to investigate the antimicrobial efficacy of chlorhexidine digluconate (CHG), a widely used antiseptic in clinical practice, alone and in combination with tea tree oil (TTO), eucalyptus oil (EO) and thymol against planktonic and biofilm cultures of S. epidermidis. METHODS Antimicrobial susceptibility assays against S. epidermidis in a suspension and in a biofilm mode of growth were performed with broth microdilution and ATP bioluminescence methods, respectively. Synergy of antimicrobial agents was evaluated with the chequerboard method. RESULTS CHG exhibited antimicrobial activity against S. epidermidis in both suspension and biofilm (MIC 2-8 mg/L). Of the essential oils thymol exhibited the greatest antimicrobial efficacy (0.5-4 g/L) against S. epidermidis in suspension and biofilm followed by TTO (2-16 g/L) and EO (4-64 g/L). MICs of CHG and EO were reduced against S. epidermidis biofilm when in combination (MIC of 8 reduced to 0.25-1 mg/L and MIC of 32-64 reduced to 4 g/L for CHG and EO, respectively). Furthermore, the combination of EO with CHG demonstrated synergistic activity against S. epidermidis biofilm with a fractional inhibitory concentration index of <0.5. CONCLUSIONS The results from this study suggest that there may be a role for essential oils, in particular EO, for improved skin antisepsis when combined with CHG.


Infection Control and Hospital Epidemiology | 2012

The Antimicrobial Efficacy of Copper Alloy Furnishing in the Clinical Environment: A Crossover Study

Tarja J. Karpanen; A.L. Casey; Peter A. Lambert; Barry Cookson; Peter Nightingale; Lisa Miruszenko; Tom Elliott

OBJECTIVE To determine whether copper incorporated into hospital ward furnishings and equipment can reduce their surface microbial load. DESIGN A crossover study. SETTING Acute care medical ward with 19 beds at a large university hospital. METHODS Fourteen types of frequent-touch items made of copper alloy were installed in various locations on an acute care medical ward. These included door handles and push plates, toilet seats and flush handles, grab rails, light switches and pull cord toggles, sockets, overbed tables, dressing trolleys, commodes, taps, and sink fittings. Their surfaces and those of equivalent standard items on the same ward were sampled once weekly for 24 weeks. The copper and standard items were switched over after 12 weeks of sampling to reduce bias in usage patterns. The total aerobic microbial counts and the presence of indicator microorganisms were determined. RESULTS Eight of the 14 copper item types had microbial counts on their surfaces that were significantly lower than counts on standard materials. The other 6 copper item types had reduced microbial numbers on their surfaces, compared with microbial counts on standard items, but the reduction did not reach statistical significance. Indicator microorganisms were recovered from both types of surfaces; however, significantly fewer copper surfaces were contaminated with vancomycin-resistant enterococci, methicillin-susceptible Staphylococcus aureus, and coliforms, compared with standard surfaces. CONCLUSIONS Copper alloys (greater than or equal to 58% copper), when incorporated into various hospital furnishings and fittings, reduce the surface microorganisms. The use of copper in combination with optimal infection-prevention strategies may therefore further reduce the risk that patients will acquire infection in healthcare environments.


Antimicrobial Agents and Chemotherapy | 2008

Penetration of Chlorhexidine into Human Skin

Tarja J. Karpanen; Tony Worthington; Barbara R. Conway; Anthony C. Hilton; T.S.J. Elliott; Peter A. Lambert

ABSTRACT This study evaluated a model of skin permeation to determine the depth of delivery of chlorhexidine into full-thickness excised human skin following topical application of 2% (wt/vol) aqueous chlorhexidine digluconate. Skin permeation studies were performed on full-thickness human skin using Franz diffusion cells with exposure to chlorhexidine for 2 min, 30 min, and 24 h. The concentration of chlorhexidine extracted from skin sections was determined to a depth of 1,500 μm following serial sectioning of the skin using a microtome and analysis by high-performance liquid chromatography. Poor penetration of chlorhexidine into skin following 2-min and 30-min exposures to chlorhexidine was observed (0.157 ± 0.047 and 0.077 ± 0.015 μg/mg tissue within the top 100 μm), and levels of chlorhexidine were minimal at deeper skin depths (less than 0.002 μg/mg tissue below 300 μm). After 24 h of exposure, there was more chlorhexidine within the upper 100-μm sections (7.88 ± 1.37 μg/mg tissue); however, the levels remained low (less than 1 μg/mg tissue) at depths below 300 μm. There was no detectable penetration through the full-thickness skin. The model presented in this study can be used to assess the permeation of antiseptic agents through various layers of skin in vitro. Aqueous chlorhexidine demonstrated poor permeation into the deeper layers of the skin, which may restrict the efficacy of skin antisepsis with this agent. This study lays the foundation for further research in adopting alternative strategies for enhanced skin antisepsis in clinical practice.


BMC Infectious Diseases | 2010

Enhanced chlorhexidine skin penetration with eucalyptus oil

Tarja J. Karpanen; Barbara R. Conway; Tony Worthington; Anthony C. Hilton; Tom Elliott; Peter A. Lambert

BackgroundChlorhexidine digluconate (CHG) is a widely used skin antiseptic, however it poorly penetrates the skin, limiting its efficacy against microorganisms residing beneath the surface layers of skin. The aim of the current study was to improve the delivery of chlorhexidine digluconate (CHG) when used as a skin antiseptic.MethodChlorhexidine was applied to the surface of donor skin and its penetration and retention under different conditions was evaluated. Skin penetration studies were performed on full-thickness donor human skin using a Franz diffusion cell system. Skin was exposed to 2% (w/v) CHG in various concentrations of eucalyptus oil (EO) and 70% (v/v) isopropyl alcohol (IPA). The concentration of CHG (μg/mg of skin) was determined to a skin depth of 1500 μm by high performance liquid chromatography (HPLC).ResultsThe 2% (w/v) CHG penetration into the lower layers of skin was significantly enhanced in the presence of EO. Ten percent (v/v) EO in combination with 2% (w/v) CHG in 70% (v/v) IPA significantly increased the amount of CHG which penetrated into the skin within 2 min.ConclusionThe delivery of CHG into the epidermis and dermis can be enhanced by combination with EO, which in turn may improve biocide contact with additional microorganisms present in the skin, thereby enhancing antisepsis.


Bioorganic & Medicinal Chemistry Letters | 2008

Thiosemicarbazones active against Clostridium difficile.

Cait Costello; Tarja J. Karpanen; Peter A. Lambert; Preena Mistry; Katy J. Parker; Daniel L. Rathbone; Jiangmeng Ren; Laura Wheeldon; Tony Worthington

A set of closely related furylidene thiosemicarbazones was prepared and screened against various clinically important Gram-positive bacteria. One compound containing an ethylene spacer and a 5-nitrofuryl group was found to have promising activity against Clostridium difficile.


Antimicrobial Agents and Chemotherapy | 2009

Permeation of chlorhexidine from alcoholic and aqueous solutions within excised human skin

Tarja J. Karpanen; Tony Worthington; Barbara R. Conway; Anthony C. Hilton; T.S.J. Elliott; Peter A. Lambert

Chlorhexidine digluconate (CHG) is widely used in the clinical setting for skin antisepsis prior to incision or insertion of medical devices, e.g., central venous catheters (11-13); however, its permeation into skin is limited (6, 7, 9, 10, 16). In a recent study, we demonstrated the limited penetration of CHG in a skin model comprising full-thickness excised human skin following the application of 2% (wt/vol) aqueous CHG (9). The aim of this current study was to compare the penetration of chlorhexidine into skin following the topical application of 2% (wt/vol) CHG in 70% (vol/vol) isopropyl alcohol (IPA) with that of aqueous CHG.


American Journal of Infection Control | 2011

A comparative study to evaluate surface microbial contamination associated with copper-containing and stainless steel pens used by nurses in the critical care unit

A.L. Casey; Tarja J. Karpanen; Debra Adams; Peter A. Lambert; Peter Nightingale; Lisa Miruszenko; Tom Elliott

A clinical study was undertaken to compare the surface microbial contamination associated with pens constructed of either a copper alloy or stainless steel used by nurses on intensive care units. A significantly lower level of microbial contamination was found on the copper alloy pens.


Journal of Infusion Nursing | 2015

An in vitro comparison of microbial ingress into 8 different needleless IV access devices.

A.L. Casey; Tarja J. Karpanen; Peter Nightingale; T.S.J. Elliott

There are conflicting reports of the effect needleless intravenous access devices have on rates of catheter-related bloodstream infection. The aim of this study was to identify any differences between the rates of microbial ingress into 8 different devices following contamination. Each type of device was subjected to a 7-day clinical simulation that involved repeated microbial contamination of the injection site and decontamination followed by saline flushes. Significant differences in the number of microorganisms associated with each device were detected in the saline eluates. Three positive-displacement mechanical valves were associated with the ingress of significantly fewer microorganisms compared with other devices.


Intensive Care Medicine | 2018

A state of the art review on optimal practices to prevent, recognize, and manage complications associated with intravascular devices in the critically ill

Jean-François Timsit; Mark E. Rupp; Emilio Bouza; Vineet Chopra; Tarja J. Karpanen; Kevin B. Laupland; Thiago Lisboa; Leonard A. Mermel; Olivier Mimoz; Jean Jacques Parienti; Garyphalia Poulakou; Bertrand Souweine; Walter Zingg

Intravascular catheters are inserted into almost all critically ill patients. This review provides up-to-date insight into available knowledge on epidemiology and diagnosis of complications of central vein and arterial catheters in ICU. It discusses the optimal therapy of catheter-related infections and thrombosis. Prevention of complications is a multidisciplinary task that combines both improvement of the process of care and introduction of new technologies. We emphasize the main component of the prevention strategies that should be used in critical care and propose areas of future investigation in this field.


Intensive Care Medicine | 2018

Chlorhexidine use in adult patients on ICU

Lila Bouadma; Tarja J. Karpanen; Tom Elliott

Chlorhexidine (CHG) is a biguanide cationic antiseptic molecule, which has been incorporated into mouthwash solutions, dental gels, dressings, washcloths and central venous catheters (CVC). It has become the first-choice antiseptic to reduce healthcare-associated infections. However, the widespread use of CHG has raised concerns about increasing rates of resistance and cross-resistance to antibiotics. In this short review the antimicrobial characteristics of CHG including microbial resistance and its main clinical applications in ICU are presented.

Collaboration


Dive into the Tarja J. Karpanen's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

A.L. Casey

University Hospitals Birmingham NHS Foundation Trust

View shared research outputs
Top Co-Authors

Avatar

T.S.J. Elliott

Queen Elizabeth Hospital Birmingham

View shared research outputs
Top Co-Authors

Avatar

Peter Nightingale

University Hospitals Birmingham NHS Foundation Trust

View shared research outputs
Top Co-Authors

Avatar

Tom Elliott

University Hospitals Birmingham NHS Foundation Trust

View shared research outputs
Top Co-Authors

Avatar

Barbara R. Conway

University of Huddersfield

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Debra Adams

National Health Service

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge